A collection of news and information related to Nektar Therapeutics published by this site and its partners.
Displaying items 1-1 of 1 » View wdbj7.com items only
ReutersAbout 48 percent of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics' experimental drug NKTR-102 in a mid-stage study, the company said. Twenty-three percent of patients on a dose schedule of once every...
Tags: Drugs and Medicines, Health, Cancer, Oncology, Breast
Jul 22, 2010 |Story| South Florida Sun-Sentinel